ArticleFrontiers in oncology2026

Secretory carrier membrane protein 3 modulates nuclear ERK1/2 signaling and drug response in triple-negative breast cancer.

Beatriz M Morales-Cabán et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.